Cubist Systematic Strategies’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $21.8M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Buy |
|
|||||
|
2024
Q3 | $8.84M | Buy |
|
|||||
|
2024
Q2 | $6.51M | Buy |
|
|||||
|
2024
Q1 | $2.66M | Sell |
|
|||||
|
2023
Q4 | $4.46M | Buy |
|
|||||
|
2023
Q3 | $12.3K | Sell |
|
|||||
|
2023
Q2 | $5.76M | Buy |
|
|||||
|
2023
Q1 | $4.84M | Buy |
|
|||||
|
2022
Q4 | $1.41M | Sell |
|
|||||
|
2022
Q3 | $2.28M | Sell |
|
|||||
|
2022
Q2 | $2.98M | Buy |
|
|||||
|
2022
Q1 | $1.44M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $658K | Buy |
|
|||||
|
2021
Q1 | $182K | Sell |
|
|||||
|
2020
Q4 | $200K | Sell |
|
|||||
|
2020
Q3 | $765K | Buy |
|
|||||
|
2020
Q2 | $226K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $248K | Buy |
|
|||||
|
2019
Q2 | $255K | Sell |
|
|||||
|
2019
Q1 | $534K | Sell |
|
|||||
|
2018
Q4 | $649K | Buy |
|
|||||
|
2018
Q3 | $13K | Sell |
|
|||||
|
2018
Q2 | $170K | Buy |
|
|||||
|
2018
Q1 | $133K | Sell |
|
|||||
|
2017
Q4 | $781K | Buy |
|
|||||
|
2017
Q3 | $99K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $161K | Sell |
|
|||||
|
2016
Q3 | $633K | Buy |
|
|||||
|
2016
Q2 | $12K | Sell |
|
|||||
|
2016
Q1 | $357K | Sell |
|
|||||
|
2015
Q4 | $1.59M | Buy |
|
|||||
|
2015
Q3 | $436K | Sell |
|
|||||
|
2015
Q2 | $590K | Buy |
|
|||||
|
2015
Q1 | $267K | Buy |
|